4 Results for "

TGF-β1/2

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "TGF-β1/2" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-115669
CAS No.: 69640-38-6
Purity:  98.88%
Synonyms: Antibiotic A 15104 Y; PClP
Target:  

Myosin TGF-β Receptor

Research Areas:  

Cancer

Pentachloropseudilin (Antibiotic A 15104 Y; PClP) is a reversible and allosteric potent inhibitor of Myo1s (class 1 myosins) with IC50s range from 1 to 5 μM for mammalian class-1 myosins and greater than 90 μM for class-2 and class-5 myosins. Pentachloropseudilin is a potent inhibitor of transforming growth factor-β (TGF-β)-stimulated signaling, with an IC50 of 0.1 to 0.2 μM for TGF-β .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100608
CAS No.: 166977-43-1
Purity:  99.13%
Synonyms: BMS-189453
Target:  

RAR/RXR

Research Areas:  

Cancer

BMS453 (BMS-189453), a synthetic retinoid, is a RARβ agonist and a RARα/RARγ antagonist. BMS453 inhibits breast cell growth predominantly through the induction of active TGFβ .
loading...
    loading...
Cat. No.: HY-124487
CAS No.: 1062624-71-8
GK-136901 is an orally active, dual Nox1/Nox4 NADPH oxidase inhibitor with a Ki of 160 nM for Nox1 and 165 nM for Nox4. GK-136901 potently blocks high glucose-induced intracellular reactive oxygen species production, p38-MAPK phosphorylation, and upregulation of TGF-β1/2 and fibronectin (fibronectin) in renal cells. GK-136901 also inhibits the proliferation of mouse pulmonary vascular cells under hypoxic conditions. GK-136901 is applicable to the research on the pathogenesis of type 2 diabetic nephropathy, high glucose-related renal lesions and pulmonary hypertension [1] .
loading...
    loading...
Cat. No.: HY-100608R
CAS No.: 166977-43-1
Synonyms: BMS-189453 (Standard)
Research Areas:  

Cancer

BMS453 (Standard) is the analytical standard of BMS453 (HY-100608). This product is intended for research and analytical applications. BMS453 (BMS-189453), a synthetic retinoid, is a RARβ agonist and a RARα/RARγ antagonist. BMS453 inhibits breast cell growth predominantly through the induction of active TGFβ .
loading...
    loading...